drugset / Trial / NCT01359098

Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa

NCT01359098

Phase 2 Completed 100 enrolled Otic Pharma
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the Safety and Efficacy of Ciprodexa Foam (0.3% Ciprofloxacin, 0.1% Dexamethasone Otic Foam), used once-a-day for 7 days for the treatment of Acute Diffuse Otitis Externa, compared to Ciprodex otic suspension used twice daily for 7 days.

Timeline

Start
2011-07
Primary completion
2011-10
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciprofloxacin Small molecule 0.3 % Other
Subject Dexamethasone Small molecule 0.1 % Other

Indications